 Researchers at the University of Oxford have developed a novel candidate vaccine against HCV NSmut. This vaccine has been inserted into the carrier viruses Chimpanzee Adenovirus 3 AdCh3 and modified vaccinia virus Ankara MVA, both of which have excellent safety records and have been previously tested in people. 